Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients

Phase 4 Completed 25 enrolled Boryung Pharmaceutical Co., Ltd Severance Hospital · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the antihypertensive efficacy and changes of neurohormonal markers of fimasartan and atenolol with exaggerated blood pressure response during exercise in essential hypertensive patients.

Timeline

Start: 2012-10
Primary completion: 2016-06
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Atenolol	Other / unclassified	50 mg	Oral
Subject	Fimasartan	Small molecule	60 mg	Oral

Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients

Summary

Timeline

Drugs

Indications